about
Efficacy of intravenous administration of combined acid suppressants in healthy dogs.Immunomodulatory effects of opioids.Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs.Adjunctive therapy with intravenous lipid emulsion and methocarbamol for permethrin toxicity in 2 cats.Ammonia concentrations in canine whole blood, EDTA-anticoagulated whole blood, and plasma measured by use of a point-of-care ammonia meter.Comparison of heparinized saline and 0.9% sodium chloride for maintaining peripheral intravenous catheter patency in dogs.Incidence of incompatible crossmatch results in dogs admitted to a veterinary teaching hospital with no history of prior red blood cell transfusion.Comparison of whole blood and plasma colloid osmotic pressure in healthy dogs.Probable vasovagal reaction following cystocentesis in two cats.Evaluation of Pulse Oximetry in Healthy Brachycephalic DogsThe frequency of oral famotidine administration influences its effect on gastric pH in cats over timeGastric perforation following endoscopic removal of a Bravo pH capsule in a catComparative analysis of the effect of IV administered acid suppressants on gastric pH in dogsEvaluation of the effect of a famotidine continuous rate infusion on intragastric pH in healthy dogsProlonged Anesthetic Recovery after Continuous Infusion of Midazolam in 2 Domestic Cats (Felis catus)Comparison of heparinized saline and 0.9% sodium chloride for maintaining central venous catheter patency in healthy dogsSupraphysiologic parenteral ascorbic acid blunts the inflammatory mediator response to pathogen associated molecular patterns in dogs ex vivoAssessment of hydromorphone and dexmedetomidine for emesis induction in cats
P50
Q36975112-DCDD7508-C26A-491E-8E17-2816F7C99D0BQ37781845-2D026A22-64C4-484E-A93D-8BC2B2B2A77DQ41060016-3935D6E8-BDCC-4B23-A84B-44A43AC930D7Q42328372-D4D25CC0-B7D2-4AAF-8AD9-F22FA13FD031Q45804889-80B7A674-4FA3-4D90-A6B4-9A965EE3A8DEQ50094216-2DB72F43-D9FB-42FD-8362-9C16612030DAQ50775380-1A6748D9-BB29-4BC5-A0F8-F34069552A3FQ50935951-46B8F514-6802-4B30-BD50-DC3CFC4DEE15Q51029854-1FB99EB9-F426-44B1-9A97-AADB7D642D96Q53706049-09BA91DA-F363-4AD0-827F-7519E46FFA44Q57056665-DBF79924-644E-4C79-87F7-87E1B9BF555BQ64276436-B39BA5A5-DC7E-49BD-8B2A-123CEC48FC47Q86925686-B1B28B31-EA42-479A-9CD3-6C12086C35F0Q89535055-2AF4694C-DF79-4E56-B028-6B9AFD0C9173Q91793498-0B5DE6FC-8F05-403C-B937-BD1241268D7FQ92639267-7398E32E-418F-4501-8BC2-4733F4D308E9Q92646120-F78436A7-B822-4C23-A847-C599A7994F7DQ92718829-E62BD67E-110F-4252-94CA-6D0796B5AEB9Q93035019-C47EE392-FA71-4333-98AA-C3002562D896
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1160-3416
@en
name
Adesola Odunayo
@ast
Adesola Odunayo
@en
Adesola Odunayo
@es
Adesola Odunayo
@nl
type
label
Adesola Odunayo
@ast
Adesola Odunayo
@en
Adesola Odunayo
@es
Adesola Odunayo
@nl
prefLabel
Adesola Odunayo
@ast
Adesola Odunayo
@en
Adesola Odunayo
@es
Adesola Odunayo
@nl
P106
P1153
36442620600
P31
P496
0000-0003-1160-3416